SecBot SecBot
8-K ·Filed Apr 17, 2026

WGRX

Wellgistics Health, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed6mo ago SEC0001493152-26-017895
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight • Neutral

Traders should monitor the closing of this transaction and the subsequent integration of the platforms. The issuance of up to $2 million in stock represents a dilutive event, and the success of the venture will depend on the realization of the anticipated synergies.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
WGRX ▼ -56.94% at T+60d
NEUTRAL call -56.94% · α vs SPY -63.72% · entry $6.60 → $2.84
Entry = T+0 close
Apr 17, 2026
via day close
T+1d
+1.82%
call +1.82% · α +2.47%
$6.72
settled 6mo ago
T+5d
-5.61%
call -5.61% · α -6.52%
$6.23
settled 6mo ago
T+20d
+31.82%
call +31.82% · α +27.62%
$8.70
settled 6mo ago
T+60d
-56.94%
call -56.94% · α -63.72%
$2.84
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Wellgistics Health formed a 51% owned joint venture, Healthstar Technologies, with Kare PharmTech, acquiring Kare Rx Hub's technology assets in exchange for $2 million in unregistered common stock. This strategic move combines their platforms to enhance patient access and streamline pharmaceutical fulfillment.

Key Financial Metrics

Deal Value
$2.0M
Deal Type
joint_venture
Offering Size
$2.0M

Key Facts

  • Wellgistics Health formed a joint venture, Healthstar Technologies, with Kare PharmTech, holding a 51% stake.
  • The deal involves acquiring Kare Rx Hub's technology assets (IP, records, etc.) in exchange for $2 million worth of Wellgistics' unregistered common stock.
  • The $2 million payment is structured as 1.5 million shares at closing, with the remainder to be paid in additional shares by April 1, 2027, based on a 2-day VWAP.
  • Kare Pharmtech agreed to a 12-month lock-up on the shares received.
  • The transaction is subject to satisfactory due diligence and is expected to close remotely.

Financial Impact

The deal has a total value of $2,000,000, paid in unregistered common stock, which will result in shareholder dilution.

dilutionequity

Risk Factors

  • The deal is subject to satisfactory due diligence, which could lead to termination.
  • The use of unregistered stock for payment will dilute existing shareholders.
  • The success of the joint venture is uncertain and depends on effective integration and market adoption.

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-017895
Exhibit: ex99-1.htm0001493152-26-017895
Document: form8-k.htm0001493152-26-017895
Document: 0001493152-26-017895-index-headers.html0001493152-26-017895
Document: 0001493152-26-017895-index.html0001493152-26-017895
Document: 0001493152-26-017895.txt0001493152-26-017895
12 reports for WGRX
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +52.70%Apr 7, 2026
Filters
Rows
Reports for WGRX — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
S-1/A
BEARISH ★ 7/10
—awaiting T+20——
May 29, 2026
21w ago
8-K
BEARISH ★ 8/10
$3.85 $3.10▲ +19.48%▲ +18.18%—
May 21, 2026
22w ago
8-K
MIXED ★ 7/10
$5.35 $3.18▼ −40.52%▼ −40.85%—
May 19, 2026
23w ago
8-K
MIXED ★ 6/10
$6.45 $3.39▼ −47.44%▼ −48.18%—
May 19, 2026
23w ago
8-K
NEUTRAL ★ 2/10
$8.40 $3.70▼ −55.95%▼ −56.94%—
May 18, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$8.70 $3.69▼ −57.59%▼ −59.17%—
May 8, 2026
24w ago
EFFECT
BEARISH ★ 6/10
$4.21 $4.35▼ −3.33%▼ −3.30%—
Apr 24, 2026
26w ago
10-K/A
BEARISH ★ 7/10
$6.23 $3.82▲ +38.68%▲ +43.64%—
Apr 17, 2026
27w ago
8-K
NEUTRAL ★ 5/10
$6.60 $8.70▲ +31.82%▲ +27.62%—
Apr 15, 2026
27w ago
S-3
NEUTRAL ★ 3/10
$7.37 $4.70▼ −36.18%▼ −42.82%—
Showing 10 of 12

US Market Status

Market Closed — Opens in 9h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026